Medical Science Liaison - Northern Region - Cardio

Medical Science Liaison - Northern Region - Cardio

Hemel Hempstead, GB

With its beginnings in a family run pharmacy in Correggio, Italy in the 1920s, Recordati is now a global pharmaceutical company, listed on the Italian stock exchange, with over 4,500 employees and turnover of over Euro 2bn. We are a group of like-minded, passionate individuals who go to extraordinary lengths for our patients, customers, partners, investors and the people across the globe who we serve.

We develop and commercialise medicines to serve people living with common diseases, as well as those living with some of the rarest, in around 150 countries. At Recordati, our mantra is simple. We’ve always believed that health, and the opportunity to live life to the fullest, is a right, not a privilege. Whether that is for common diseases or the rarest – we want to give people the opportunity to be the best version of themselves.

This drive will never stop. Together, we will always be reimagining tomorrow – with new ideas, new technologies and new innovations to fight diseases. Recordati. Unlocking the full potential of life.

Reporting to the Medical Director, the Medical Scientific Liaison (MSL), will lead the medical and scientific activities within the Northern region of the UK to inform and educate physicians, support staff, payers and any other relevant industry groups on Recordati’s portfolio. The MSL must also support and comply with all relevant internal and external regulations, guidelines and policies at both local and international level.

• To established as an internal and external product and disease area expert including treatment guidelines, protocols, engage in discussions on and support clinical research projects including real world data studies.
• To respond in a timely manner to unsolicited requests from healthcare professionals for medical/scientific information.
• To communicate and disseminate scientific information across the internal and external stakeholder groups.
• To deliver internal and external product and disease state training as required.
• To monitor and maintain up to date knowledge on all products and company’s activities relevant to the disease area.
• Responsibility for attending national and international scientific meetings, as required, to gather current scientific information and to address HCP’s unsolicited questions.

• To serve as the primary scientific contact with Health Care Professionals at a Regional or National level on the specific disease area(s).
• To support clinical development activities in the assigned therapy area(s).
• To organise and engage in medical interactions with KOLs.
• To build relationships with external experts (e.g. Health Care Professionals, Payers, Patient groups), through robust, scientific dialogue.
• To work cross functionally to connect KOLs with other internal and external parties as appropriate.
• To support specific events as required by the company including KOL led meetings and medical symposia, advisory board meetings and congresses.
• To identify and develop potential areas of medical collaboration with KOLs.
• To work with the local, regional, national and international collaborative groups, guidelines committees as needed to ensure accurate and timely dissemination of product and disease state information.
• To identify suitable publication projects through ongoing relationships with KOLs.
• To engage in discussions on and support clinical research projects including real world data studies.

• To maintain knowledge on current treatment pathways, protocols and practices across defined geographical area.
• To ensure and up to date knowledge of hospitals, KOLs, competitor activities, studies, trends, influencers, formularies, buyers, reimbursement providers across area.
• To support clinical development activities in the assigned therapy area if relevant (such as site identification and assessment; safety and product training for external clinical trial teams; addressing study subject retention and other scientific issues in partnership with the clinical operations and medical teams).

• T…